0001669191-18-000554.txt : 20181220 0001669191-18-000554.hdr.sgml : 20181220 20181220164022 ACCESSION NUMBER: 0001669191-18-000554 CONFORMED SUBMISSION TYPE: C/A PUBLIC DOCUMENT COUNT: 9 FILED AS OF DATE: 20181220 DATE AS OF CHANGE: 20181220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Phoenix PharmaLabs Inc CENTRAL INDEX KEY: 0001755778 IRS NUMBER: 731626743 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C/A SEC ACT: 1933 Act SEC FILE NUMBER: 020-24785 FILM NUMBER: 181246632 BUSINESS ADDRESS: STREET 1: 999 WEST 1500 SOUTH, BUILDING 600 CITY: WOODS CROSS STATE: UT ZIP: 84087 BUSINESS PHONE: 8014200285 MAIL ADDRESS: STREET 1: 999 WEST 1500 SOUTH STREET 2: BUILDING 600 CITY: WOODS CROSS STATE: UT ZIP: 84087 C/A 1 primary_doc.xml C/A 0001755778 XXXXXXXX 020-24785 LIVE false true false false issuer extended offering deadline. Phoenix PharmaLabs Inc Corporation UT 01-23-2002 999 West 1500 South Building 600 Woods Cross UT 84087 www.phoenixpharmalabs.com NetCapital Funding Portal Inc. 0001669191 007-00035 283596 Up to 4.9% of amount raised for a successful offering and a listing fee of up to $5,000 None. Common Stock 12346 0.81000 At issuer's discretion. 10000.26 Y First-come, first-served basis 1069999.47 02-15-2019 5 151050.00 29757.00 151025.00 29732.00 0.00 0.00 1871549.00 1417549.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1094446.00 -1270142.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY B5 GU 1V PR VI Phoenix PharmaLabs Inc William W Crossman Principal Executive Officer William W Crossman Principal Executive Officer 10-10-2018 Timmy Chou Principal Financial Officer 10-10-2018 Timmy Chou Principal Accounting Officer 10-10-2018 Timmy Chou Board Member 10-10-2018 Lawrence Toll Board Member 10-10-2018 John A Lawson Board Member 10-10-2018 Chris Tew Board Member 10-10-2018 William W Crossman Board Member 10-10-2018 EX-99 2 offeringstatement.pdf OFFERING STATEMENT PDF begin 644 offeringstatement.pdf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